# Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dual-vascular-endothelial-growth-factor-receptor-and-fibroblast-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haijing Deng,Anna Kan,Ning Lyu,Luwen Mu,Yi Han,Longzhong Liu,Yanyu Zhang,Youfa Duan,Shuangye Liao,Shaolong Li,Qiankun Xie,Tianxiao Gao,Yanrong Li,Zhenfeng Zhang,Ming Zhao |
| Citations | 179 |
| DOI | 10.1159/000505695 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.karger.com/Article/Pdf/505695 |
| OpenAlex ID | https://openalex.org/W3008414152 |
| PMID | 32647635 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yanrong Li](https://scholariq.org/researchers/yanrong-li/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.